Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 0.00% is 100% above its 1-year average of -116.71%, near the high end of its 1-year range (-683.56%–100.00%).
100.00% above its 12-month average of -116.71%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
-116.71%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Tenaya Therapeutics, Inc.
Market Cap
$118.59M
Gross Margin
0.00%
TTM Avg
-116.71%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$118.83M
Gross Margin
90.14%
TTM Avg
48.16%
3Y Avg
49.08%
5Y Avg
32.72%
Market Cap
$117.76M
Gross Margin
0.00%
TTM Avg
50.00%
3Y Avg
50.00%
5Y Avg
33.33%
Market Cap
$119.84M
Gross Margin
-62.76%
TTM Avg
-61.84%
3Y Avg
-230.63%
5Y Avg
-163.28%
Market Cap
$120.58M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$115.67M
Gross Margin
89.22%
TTM Avg
94.61%
3Y Avg
97.31%
5Y Avg
-2138.81%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | $118.59M | 0.00% | -116.71% | 0.00% | 0.00% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | 90.14% | 48.16% | 49.08% | 32.72% |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | 0.00% | 50.00% | 50.00% | 33.33% |
| Cibus, Inc. (CBUS)vs › | $119.84M | -62.76% | -61.84% | -230.63% | -163.28% |
| Seer, Inc. (SEER)vs › | $120.41M | 46.31% | 49.33% | 27.70% | -6.64% |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 79.43% | 81.39% | 84.94% | 86.41% |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | 89.22% | 94.61% | 97.31% | -2138.81% |
| BGM Group Ltd. (BGM)vs › | $121.55M | 12.79% | 14.59% | 10.64% | 11.25% |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 34.65% | 28.86% | 24.17% | 16.11% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | -683.56% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
